Brief: Oragenics Announce Changes In Management And Board Of Directors
03/05/2021 13:19
May 3 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS ANNOUNCE CHANGES IN MANAGEMENT AND BOARD OF
DIRECTORS
* ORAGENICS INC - ALAN JOSLYN RESIGNED AS CEO, PRESIDENT AND
DIRECTOR
* ORAGENICS INC - DURING INTERIM PERIOD BEFORE A NEW CEO IS
HIRED,
BOARD WILL PROVIDE DIRECTION TO CO
Source text for Eikon: ID:nBw7bMmqsa
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing